Advertisements

Contact Jackie to advertise here - £75/month

 

 

 

...........................

 

 

 

ESH Community - Supporting drug and alcohol service providers across the UK!

 

We're a small and focused residential drug and alcohol treatment centre based in Warwickshire providing medically monitored detox and rehabilitation services. We have recently been assessed by CQC in May 2026 and we're proud to announce we have again been rated GOOD by CQC in all categories.

Give us a call to see how we can help.

 

 

...........................

 

University West of Scotland Contemporary Drug & Alcohol Studies

UWS’s Postgraduate Programme in Contemporary Drug & Alcohol Studies (CDAS) is a fantastic course for people looking to study, work and research in this area, and for practitioners looking to develop their practice. The course is grounded in the UK and global in outlook. Students are supported to:

- examine social, cultural, and political influences on drug/alcohol use and policies,

- explore the evidence for responses that reduce harms and support recovery,

- undertake a work-based placement to apply learning into practice.

We offer a range of study options and a supportive student-centred learning environment. For more information email Programme Lead April.Shaw@uws.ac.uk or click on this link

 

...........................

 

 

ESH Community – maintaining last year’s prices for the start of 2025!

We’re a small not-for-profit residential drug and alcohol rehab centre providing professional medically assisted detox and rehabilitation services, and although everyone’s costs to provide services are increasing we’ve decided to maintain last year’s prices for the start of 2025. 

 

Give us a call to see how we can help.

 

...........................

 

Comments / sponsorship

If you have any comments about DrugWise Daily or to find out about sponsorship please contact the Editor: Jackie Buckle

 

 

Disclaimer

DrugWise Daily, X, BlueSky and Facebook are intended purely as current awareness resources. DrugWise Daily does not endorse nor guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. See our editorial policy here

 

 

 

 

Thank you to our Premium sponsors:
Could you sponsor DrugWise Daily? Please Email Harry Shapiro to discuss

 

Reports September

 

Half of ketamine samples tested contained other harmful substances posing health risk, new report reveals

Testing of ketamine samples from across Greater Manchester has found a large variation of purity with half of samples containing harmful substances posing health risks, according to the latest review of drug use across the region. Commissioned by Greater Manchester Combined Authority (GMCA) and led by researchers from Manchester Metropolitan University, GM TRENDS is an emergent drug trends monitoring system that identifies changing patterns of drug use across Greater Manchester local authorities | MMU, UK

National naloxone programme Scotland - Quarterly monitoring bulletin

This release by Public Health Scotland (PHS) presents information on the number of take-home naloxone kits issued by the National Naloxone Programme (NNP) in Scotland (January to March 2025/26) | PHS, UK

Smokefree generation communications toolkit

On 1st January 2027 the UK will become only the second country in the world to introduce a ‘smokefree generation’ by continuously raising the age of sale for tobacco. This communications toolkit contains resources to help you maximise the opportunity that this presents for the benefit of public health and play your part to ensure it is a success | ASH, UK

Experiences of MAT standards implementation for people who use cocaine and crack

Scotland has adopted national standards on drug-based treatment of problem substance use. What difference have they made in relation to their cocaine use for opioid-dependent patients being prescribed methadone or buprenorphine? | SDF, UK

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Home : Terms of use : Contact
Copyright DrugWise©2026